Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
CorEvitas, LLC logo — Regulatory grade real-world evidence and clinical insights o...

CorEvitas, LLC

Regulatory grade real-world evidence and clinical insights on post approval safety and effectiveness for novel therapies

Founded 2001 United States Waltham, United States 249 employees Private Equity Analytics, Biopharma +4

General Information

Company Name CorEvitas, LLC
Founded Year 2001
Location United States Waltham, United States
Founders / Decision Makers
Team member
Employees 249
Industries Analytics, Biopharma, Biotechnology +3
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with CorEvitas, LLC. To contact CorEvitas, LLC, visit corevitas.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CorEvitas, LLC compare?

A PDF of CorEvitas, LLC and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CorEvitas, LLC soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CorEvitas, LLC

CorEvitas, LLC, established in 2000 and headquartered in the United States, has positioned itself as a leader in providing science-led, regulatory grade real-world evidence and clinical insights for post-approval safety and effectiveness of novel therapies. The company's offerings include syndicated registry data, analytics, patient experience and insights, precision medicine solutions, and specialty EMR and claims data. Its slogan, "Regulatory grade real-world evidence and clinical insights on post approval safety and effectiveness for novel therapies," encapsulates its focus. CorEvitas, LLC's significant investment milestone was marked by a Private Equity Round investment on 19 December 2019, with the backing of investors including Audax Private Equity and Ardan Equity. The firm's impact within the life sciences industry is underscored by its contribution to hundreds of peer-reviewed manuscripts and abstracts, underscoring its pivotal role in supporting regulatory commitments for new drug approvals through active safety surveillance and formal post-authorization safety studies. As the company continues to bolster its presence in the Analytics, Biopharma, Biotechnology, and Health Care sectors, CorEvitas, LLC sets itself apart with its provision of objective clinical insights, shaping the landscape for evidence-based decision-making in the healthcare and life sciences domains.

Business keywords: real-world evidence, clinical insights, post-approval safety, effectiveness, novel therapies, registry data, precision medicine, specialty EMR, claims data, biopharmaceutical, autoimmune registries, patient reported outcomes, longitudinal studies, health economics and outcomes research

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round Undisclosed 2
Audax Private Equity Ardan Equity
Audax Private Equity, Ardan Equity
19 Dec 2019

CorEvitas, LLC Alternatives & Competitors

CorEvitas, LLC vs
Embleema
Embleema United States

Regulatory-grade real-world data platform for registries, research teams, and patient-driven discove...

Series A
30 employees
Biotechnology, Health Care
CorEvitas, LLC vs
Human Data Sciences
Human Data Sciences United Kingdom

Experts in real-world evidence generation. Delivering intelligence in minutes and studies in days —...

Venture round
38 employees
Biotechnology, Health Care
CorEvitas, LLC vs
Promptly Health
Promptly Health Portugal

Real-world evidence for a better healthcare

Non Equity Assistance
56 employees
Analytics, Big Data
Compare CorEvitas, LLC vs Promptly Health

FAQ About CorEvitas, LLC

Regulatory grade real-world evidence and clinical insights on post approval safety and effectiveness for novel therapies
CorEvitas, LLC was founded in 2001.
CorEvitas, LLC is headquartered in Waltham, United States.
CorEvitas, LLC operates in Analytics, Biopharma, Biotechnology, Data Analytics, Health Care and Marketing. Its work centres on real-world evidence, clinical insights, post-approval safety and effectiveness.
CorEvitas, LLC has approximately 249 employees.
CorEvitas, LLC has completed 1 funding round. The latest funding stage is Private Equity.
Top alternatives and competitors to CorEvitas, LLC include Embleema, Human Data Sciences, Promptly Health, ConcertAI, REPROSENT. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CorEvitas, LLC and Embleema are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CorEvitas, LLC, https://bouncewatch.com/company/corevitas-llc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes